This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Jay D. Miller Appointed Chief Executive Officer

Stocks in this article: IM IMRS

WINNIPEG and MINNEAPOLIS, July 29, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced that Jay D. Miller, the company's current President and COO, will also become the CEO of IMRIS Inc., effective August 1, 2013.  Chairman and CEO David Graves will continue as the Chair of the Board of Directors of the Corporation.

"IMRIS has grown from a single idea into a business that impacts the lives of patients every day," said David Graves.  "Our company has sold systems all over the world and is well positioned to enter into this next stage of growth under Jay's leadership.  Since our inception we have successfully commercialized intraoperative surgery systems based on MR and now we have completed the intraoperative CT, which has the ability to put another strong revenue stream into the company.  We have built a global sales capacity and customer base and have navigated some of the most challenging economic conditions in recent times.  We are on track for the completion of the Symbis ® Surgical System, our MR-compatible Surgical Robot, and our MR-guided Radiation Therapy platform.  We have a compelling line up of in-the-market and development stage products that will provide a strong foundation for the company as it goes forward.   The goal of all IMRIS products is to improve patient outcomes and reduce the cost of care in the treatment of disease."

"The innovation and technology foundation at IMRIS was instrumental in my decision to join the company," said Jay Miller.  "IMRIS is infused with a culture of excellence and a proven ability to commercialize technology.  It is my goal to drive the adoption of products and services by customers and to provide great returns for investors.  This is an exciting opportunity to lead the next phase in the growth of a world class medical device company."

Miller joined IMRIS in September 2012 as President and COO.  Miller previously was the CEO of Zonare Inc., and CEO of Vital Images.  Prior to that he held senior positions with GE Healthcare after starting his career with Siemens Medical Systems.  He has a BA from Dartmouth, an MSc in Biomedical Engineering from University of Virginia and an MBA from Kellogg.

About IMRIS IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS ® Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. VISIUS ® Surgical Theatres serve the neurosurgical, spine, cardiovascular and cerebrovascular markets.

SOURCE IMRIS Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,580.51 +223.64 1.29%
S&P 500 2,037.11 +24.22 1.20%
NASDAQ 4,706.0550 +61.7430 1.33%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs